SBS226

N/A

Report date: 2023/02/13 17:54:03
NME

Base Information

Drug NameSBS226
Drug Alias NameSBS226SBS-226
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsδ-opioid receptor antagonists
TargetsMu opioid receptorδ-opioid receptor
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSparian Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSparian Biosciences Inc
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A